IBD Stock Of The Day: Progyny has a first-ever buy point from an IPO base. The fertility services firm, with key clients Microsoft and Google, is profitable. Earnings are due Wednesday. Read More...
IBD Stock Of The Day: Profitable IPO Progyny Nears First-Ever Buy Point
IBD Stock Of The Day: Progyny has a first-ever buy point from an IPO base. The fertility services firm, with key clients Microsoft and Google, is profitable. Earnings are due Wednesday.
Add Comment